EP3730132
COMPOSITION FOR USE IN A METHOD OF TREATING OVERWEIGHT AND OBESITY IN PATIENTS WITH HIGH CARDIOVASCULAR RISK
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.6.2013EP published:
4.5.2022EP application number:
20165284.9
EPO information:
European Patent Register
Max expiry date:
4.6.2033
Title in English:
COMPOSITION FOR USE IN A METHOD OF TREATING OVERWEIGHT AND OBESITY IN PATIENTS WITH HIGH CARDIOVASCULAR RISKLanguage of the patent:
English
Timeline
Today
5.6.2013EP application
4.5.2022EP Publication
Owner
Name:
Nalpropion Pharmaceuticals LLCAddress:
155 Franklin Rd, Suite 450, Brentwood, TN 37027, US
Inventor
Name:
KLASSEN, PrestonAddress:
La Jolla, CA 92037, US
Name:
TAYLOR, KristinAddress:
San Diego, CA 92127, US
Priority
Number:
201261656451 PDate:
6.6.2012Country:
US
Classification
Categories:
A61K 31/137, A61K 31/485, A61P 3/04, A61P 9/00, A61P 9/04, A61P 9/10, A61K 9/20, G01G 19/414, G09B 5/06, G09B 19/00, G16H 20/10